BioPharma Resources

Company · BIIB

Biogen

Includes drugs filed under related and acquired sponsor names. Trials are searched under: Biogen.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

12

12 still marketed

Novel approvals

10

Approvals since 2021

12

Originals and new uses

Phase 3 trials

94

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

  • Zurzuvae new use Priority reviewNov 13, 2026
  • Spinraza new use OrphanMar 27, 2026
  • Skyclarys new use OrphanDec 20, 2024
  • Tofidence approved Sep 29, 2023
  • Zurzuvae approved NovelPriority reviewAug 4, 2023
  • Qalsody approved NovelAccelerated approvalPriority reviewOrphanApr 25, 2023
  • Skyclarys approved NovelPriority reviewOrphanFeb 28, 2023
  • Tecfidera new use Feb 10, 2023
  • Vumerity new use Feb 10, 2023
  • Aduhelm new use Feb 8, 2023

Drugs in development (8)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • FelzartamabPhase 38 trials

    Biogen · Antibody-mediated Rejection, Microvascular Inflammation, Graves' Disease

  • LitifilimabBIIB059Phase 35 trials

    Biogen · Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus, Lupus Erythematosus, Systemic

  • SalanersenBIIB115Phase 33 trials

    Biogen · Muscular Atrophy, Spinal, Spinal Muscular Atrophy

  • DNL151BIIB122Phase 22 trials

    Denali Therapeutics Inc. · Parkinson Disease

  • BGC101autologous EnEPC preparationPhase 21 trial

    Biogen · Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease

  • BIIB091Phase 21 trial

    Biogen · Relapsing Forms of Multiple Sclerosis

  • BIIB147Phase 21 trial

    Biogen · Amyotrophic Lateral Sclerosis

  • DiranersenISIS 814907, BIIB080Phase 21 trial

    Biogen · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia

Recruiting Phase 3 trials

Largest first.

Marketed drugs (12)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.